The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma - A systematic review and meta-analysis

被引:100
作者
Schorn, Stephan [1 ]
Demir, Ihsan Ekin [1 ]
Haller, Bernhard [2 ]
Scheufele, Florian [1 ]
Reyes, Carmen Mota [1 ]
Tieftrunk, Elke [1 ]
Sargut, Mine [1 ]
Goess, Ruediger [1 ]
Friess, Helmut [1 ]
Ceyhan, Guralp Onur [1 ]
机构
[1] Tech Univ Munich, Dept Surg, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany
[2] Tech Univ Munich, Inst Med Stat & Epidemiol, Klinikum Rechts Isar, Munich, Germany
来源
SURGICAL ONCOLOGY-OXFORD | 2017年 / 26卷 / 01期
关键词
Pancreatic cancer; Neural invasion; Survival; Overall survival; Recurrence-free survival; Disease-free-survival; Systematic review; Meta-analysis; LYMPH-NODE RATIO; PAPILLARY MUCINOUS NEOPLASM; LONG-TERM SURVIVAL; PERINEURAL INVASION; PROGNOSTIC-FACTORS; UNFAVORABLE PROGNOSIS; ADJUVANT CHEMOTHERAPY; DISTAL PANCREATECTOMY; DECREASED SURVIVAL; CURATIVE RESECTION;
D O I
10.1016/j.suronc.2017.01.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To assess the impact of neural invasion/NI on overall survival/OS and tumor recurrence in pancreatic ductal adenocarcinoma/PDAC. Summary background data: NI is a histopathological hallmark of PDAC. Although some studies suggested an important role for NI on OS, disease-free/DFS and progression-free survival/PFS in PDAC, there is still no consensus on the actual role of NI on survival and local recurrence in PDAC. Methods: Pubmed, Cochrane library, Ovid and Google Scholar were screened for the terms "pancreatic ductal adenocarcinoma", "pancreatic cancer", "survival", "tumor recurrence" and " perineural invasion". The PreferredeReporting-Items-for-Systematic-review-and-Meta-Analysis/PRISMA-guidelines were used for systematic review and meta-analysis. Articles meeting predefined criteria were critically analysed on relevance, and meta-analyses were performed by pooling univariate and multivariate hazard ratios/HR. Results: A total number of 25 studies on the influence of NI on tumor recurrence, and 121 studies analysing the influence of NI on survival were identified by systematic review. The HR of the univariate (HR 1.88; 95%-CI 1.71-2.07; p < 0.00001) and multivariate meta-analysis (HR 1.68; 95%-CI 1.47-1.92; p < 0.00001) showed a major impact of NI on OS. Likewise, NI was associated with decreased DFS (HR 2.53; 95%-CI: 1.67-3.83; p =0.0001) and PFS (HR 2.41; 95%-CI: 1.73-3.37: p < 0.00001) multivariate meta-analysis. Conclusions: Although the power of this study is limited by missing pathological procedures to assess the true incidence of NI, NI appears to be an independent prognostic factor for OS, DFS and PFS in PDAC. Therefore, NI should be increasingly considered in patient stratification and in the development of novel therapeutic algorithms. (C) 2017 Published by Elsevier Ltd.
引用
收藏
页码:105 / 115
页数:11
相关论文
共 102 条
  • [1] Prognostic factors in pancreatic cancer
    Andren-Sandberg, Ake
    [J]. NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, 2012, 4 (01) : 9 - 12
  • [2] Biglycan expression and clinical outcome in patients with pancreatic adenocarcinoma
    Aprile, Giuseppe
    Avellini, Claudio
    Reni, Michele
    Mazzer, Micol
    Foltran, Luisa
    Rossi, Diego
    Cereda, Stefano
    Iaiza, Emiliana
    Fasola, Gianpiero
    Piga, Andrea
    [J]. TUMOR BIOLOGY, 2013, 34 (01) : 131 - 137
  • [3] Is the Need for an Arterial Resection a Contraindication to Pancreatic Resection for Locally Advanced Pancreatic Adenocarcinoma? A Case-Matched Controlled Study
    Bachellier, Philippe
    Rosso, Edoardo
    Lucescu, Ionut
    Oussoultzoglou, Elie
    Tracey, Jacky
    Pessaux, Patrick
    Ferreira, Nelio
    Jaeck, Daniel
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2011, 103 (01) : 75 - 84
  • [4] Positive Expression of L1-CAM is Associated with Perineural Invasion and Poor Outcome in Pancreatic Ductal Adenocarcinoma
    Ben, Qi-Wen
    Wang, Jian-Cheng
    Liu, Jun
    Zhu, Ying
    Yuan, Fei
    Yao, Wei-Yan
    Yuan, Yao-Zong
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (08) : 2213 - 2221
  • [5] Clinical profiles and long-term outcomes of patients with pancreatic ductal adenocarcinoma and diabetes mellitus
    Ben, Qiwen
    Xu, Maojin
    Jiang, Ying
    Yuan, Yaozong
    Wang, Kaixuan
    Fang, Jun
    Li, Zhaoshen
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2012, 28 (02) : 169 - 176
  • [6] DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma
    Biankin, AV
    Morey, AL
    Lee, CS
    Kench, JG
    Biankin, SA
    Hook, HC
    Head, DR
    Hugh, TB
    Sutherland, RL
    Henshall, SM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (23) : 4531 - 4542
  • [7] INTERACTION OF PANCREATIC DUCTAL CARCINOMA WITH NERVES LEADS TO NERVE DAMAGE
    BOCKMAN, DE
    BUCHLER, M
    BEGER, HG
    [J]. GASTROENTEROLOGY, 1994, 107 (01) : 219 - 230
  • [8] BOTTGER T, 1990, ACTA CHIR SCAND, V156, P781
  • [9] Factors influencing survival after resection for periampullary neoplasms
    Bouvet, M
    Gamagami, RA
    Gilpin, EA
    Romeo, O
    Sasson, A
    Easter, DW
    Moossa, AR
    [J]. AMERICAN JOURNAL OF SURGERY, 2000, 180 (01) : 13 - 17
  • [10] Adenocarcinoma of the pancreas: Does prognosis depend on mode of lymph node invasion?
    Buc, E.
    Couvelard, A.
    Kwiatkowski, F.
    Dokmak, S.
    Ruszniewski, P.
    Hammel, P.
    Belghiti, J.
    Sauvanet, A.
    [J]. EJSO, 2014, 40 (11): : 1578 - 1585